These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 176399

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Lack of M-MuSV tumour regression associated with T lymphocyte tolerance.
    Chieco-Bianchi L, Collavo D, Zanovell P, De Rossi A, Davies AJ.
    Nature; 1980 Jun 26; 285(5767):667-8. PubMed ID: 6248790
    [No Abstract] [Full Text] [Related]

  • 4. Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus.
    Kirchner H, Chused TM, Herberman RB, Holden HT, Lavrin DH.
    J Exp Med; 1974 Jun 01; 139(6):1473-87. PubMed ID: 4598016
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
    Lamon EW, Whitten HD, Skurzak HM, Andersson B, Lidin B.
    J Immunol; 1975 Nov 01; 115(5):1288-94. PubMed ID: 1080777
    [Abstract] [Full Text] [Related]

  • 7. Immunological study of two stocks of Moloney sarcoma virus producing regressor and progressor tumors in C57BL/6 mice.
    Takeichi N, Boone CW, Holden HT, Herberman RB.
    Int J Cancer; 1978 Jan 15; 21(1):78-84. PubMed ID: 203543
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Monoclonal IgM antibodies that inhibit primary Moloney murine sarcoma growth.
    Lamon EW, Powell TJ, Walia AS, Lidin BI, Srinivas RV, Baskin JG, Kearney JF.
    J Natl Cancer Inst; 1987 Mar 15; 78(3):547-56. PubMed ID: 3469466
    [Abstract] [Full Text] [Related]

  • 11. Colonizing capacity of lymphoid cells injected into syngeneic hosts.
    Kastelan A, Springer O, Bunarević A.
    Adv Exp Med Biol; 1973 Mar 15; 29(0):43-8. PubMed ID: 4604242
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Thymosin, a thymic hormone influencing lymphoid cell immunological competence.
    White A, Goldstein AL.
    Ciba Found Study Group; 1970 Mar 15; 36():3-23. PubMed ID: 4399435
    [No Abstract] [Full Text] [Related]

  • 15. Cytostasis of lymphoma cells in suspension: probable non-thymic origin of the cytostatic lymphoid cells in mice bearing mys -induced tumors.
    Senik A, de Giorgi L, Gomard E, Levy JP.
    Int J Cancer; 1974 Sep 15; 14(3):396-400. PubMed ID: 4376521
    [No Abstract] [Full Text] [Related]

  • 16. Tumor inhibiting capacity of spleen and lymph node cells from mice with murine sarcoma virus (MSV-M)-induced tumors.
    Weiland E, Mussgay M.
    Z Immunitatsforsch Exp Klin Immunol; 1975 Nov 15; 150(5):414-23. PubMed ID: 181922
    [Abstract] [Full Text] [Related]

  • 17. Effect of thymectomy on tumor development and on T and B lymphocytes in tumor-bearing rats.
    Klobusická M, Koníková E, Novotná L.
    Neoplasma; 1979 Nov 15; 26(4):413-21. PubMed ID: 392324
    [Abstract] [Full Text] [Related]

  • 18. STUDIES ON IMMUNOLOGIC RECONSTITUTION OF THYMECTOMIZED MICE.
    YUNIS EJ, HILGARD HR, MARTINEZ C, GOOD RA.
    J Exp Med; 1965 Apr 01; 121(4):607-32. PubMed ID: 14276780
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.